NO20080754L - Rotavirusvaksine som induserer heterotypisk kryss-beskyttelse - Google Patents

Rotavirusvaksine som induserer heterotypisk kryss-beskyttelse

Info

Publication number
NO20080754L
NO20080754L NO20080754A NO20080754A NO20080754L NO 20080754 L NO20080754 L NO 20080754L NO 20080754 A NO20080754 A NO 20080754A NO 20080754 A NO20080754 A NO 20080754A NO 20080754 L NO20080754 L NO 20080754L
Authority
NO
Norway
Prior art keywords
induces
protection
rotavirus vaccine
heterotypic cross
heterotypic
Prior art date
Application number
NO20080754A
Other languages
English (en)
Inventor
Brigitte Desiree Alberte Colau
Beatrice Arsene Virginie De Vos
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0516944A external-priority patent/GB0516944D0/en
Priority claimed from GB0521164A external-priority patent/GB0521164D0/en
Priority claimed from GB0608962A external-priority patent/GB0608962D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20080754L publication Critical patent/NO20080754L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Oppfinnelsen tilveiebringer en metode for å fremkalle en immunrespons mot rotavirus-stamme, hvor metoden omfatter administrering til et individ et preparat omfattende en svekket rotavirus-stamme av en GxPy-type, idet nevnte preparat genererer en immunrespons mot en rotavirus-stamme som hverken er en Gx- eller en Py-type.
NO20080754A 2005-08-17 2008-02-12 Rotavirusvaksine som induserer heterotypisk kryss-beskyttelse NO20080754L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0516944A GB0516944D0 (en) 2005-08-17 2005-08-17 Vaccine
GB0521164A GB0521164D0 (en) 2005-10-18 2005-10-18 Vaccine
GB0608962A GB0608962D0 (en) 2006-05-05 2006-05-05 Vaccine
PCT/EP2006/008094 WO2007020078A2 (en) 2005-08-17 2006-08-15 Rotavirus vaccine inducing heterotypic cross protection

Publications (1)

Publication Number Publication Date
NO20080754L true NO20080754L (no) 2008-05-15

Family

ID=37757924

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080754A NO20080754L (no) 2005-08-17 2008-02-12 Rotavirusvaksine som induserer heterotypisk kryss-beskyttelse

Country Status (25)

Country Link
US (1) US20090028828A1 (no)
EP (2) EP1915173A2 (no)
JP (1) JP5519934B2 (no)
KR (1) KR20080036648A (no)
AR (1) AR054916A1 (no)
AU (1) AU2006281566B2 (no)
BR (1) BRPI0615203A2 (no)
CA (1) CA2619751C (no)
CR (1) CR9759A (no)
CY (1) CY1116135T1 (no)
DK (1) DK2233153T3 (no)
EA (1) EA014328B1 (no)
ES (1) ES2534637T3 (no)
HR (1) HRP20150310T1 (no)
IL (1) IL189289A0 (no)
MA (1) MA29700B1 (no)
MX (1) MX2008002270A (no)
NO (1) NO20080754L (no)
PE (1) PE20070235A1 (no)
PL (1) PL2233153T3 (no)
PT (1) PT2233153E (no)
SG (1) SG163571A1 (no)
SI (1) SI2233153T1 (no)
TW (1) TW200740457A (no)
WO (1) WO2007020078A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107510D0 (en) 2001-03-26 2001-05-16 Univ Bristol New elongase gene and a process for the production of -9-polyunsaturated fatty acids
US8241886B2 (en) 2007-09-25 2012-08-14 Aridis Pharmaceuticals Formulations for preservation of rotavirus
US9311112B2 (en) * 2009-03-16 2016-04-12 Apple Inc. Event recognition
KR20150000389A (ko) * 2011-04-28 2015-01-02 인터내셔널 메디카 파운데이션 액상 백신 제제
JP6126684B2 (ja) * 2012-04-23 2017-05-10 バハラ バイオテック インターナショナル リミテッド 新規なロタウイルスワクチン組成物及び同組成物を調製する方法
WO2017062246A1 (en) 2015-10-05 2017-04-13 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Human rota virus g9p[6] strain and use as a vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2121841T3 (es) * 1990-11-16 1998-12-16 Childrens Hosp Medical Center Una vacuna para proporcionar proteccion inmunologica contra enfermedades de rotavirus en humanos.
DK1212084T3 (da) * 1999-08-17 2006-07-10 Glaxosmithkline Biolog Sa Fremgangsmåde til adskillelse af rotavirus-varianter samt levende, svækket rotavirus-vaccine
EP2272532B1 (en) * 2003-09-02 2016-02-10 GlaxoSmithKline Biologicals S.A. Rotavirus vaccine

Also Published As

Publication number Publication date
CR9759A (es) 2008-05-05
AU2006281566B2 (en) 2011-09-01
HRP20150310T1 (hr) 2015-06-19
DK2233153T3 (da) 2015-04-27
US20090028828A1 (en) 2009-01-29
TW200740457A (en) 2007-11-01
EA200800320A1 (ru) 2008-10-30
EA014328B1 (ru) 2010-10-29
SI2233153T1 (sl) 2015-05-29
CA2619751A1 (en) 2007-02-22
JP2009504701A (ja) 2009-02-05
PL2233153T3 (pl) 2015-06-30
JP5519934B2 (ja) 2014-06-11
EP1915173A2 (en) 2008-04-30
EP2233153B1 (en) 2015-01-21
AU2006281566A1 (en) 2007-02-22
IL189289A0 (en) 2008-06-05
AR054916A1 (es) 2007-07-25
CY1116135T1 (el) 2017-02-08
BRPI0615203A2 (pt) 2011-05-10
WO2007020078A3 (en) 2007-05-24
CA2619751C (en) 2016-07-05
EP2233153A1 (en) 2010-09-29
MA29700B1 (fr) 2008-08-01
SG163571A1 (en) 2010-08-30
WO2007020078A2 (en) 2007-02-22
PT2233153E (pt) 2015-04-20
MX2008002270A (es) 2008-03-27
PE20070235A1 (es) 2007-04-04
KR20080036648A (ko) 2008-04-28
ES2534637T3 (es) 2015-04-27

Similar Documents

Publication Publication Date Title
NO20080754L (no) Rotavirusvaksine som induserer heterotypisk kryss-beskyttelse
JO3257B1 (ar) مركبات وتركيبات كمعدلات لفاعلية tlr
NO20074238L (no) Fiksert dosering av HER-antistoffer
EA201301320A1 (ru) 4-арил-n-фенил-1,3,5-триазин-2-амины, которые содержат сульфоксиминную группу
PH12015501003A1 (en) 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
SG178954A1 (en) Immunogenic compositions including tlr activity modulators
EA201291133A1 (ru) Антитела, обладающие пониженной иммуногенностью в организме человека
EA201000903A1 (ru) Антитела к pcrv-антигену pseudomonas aeruginosa
NO20074824L (no) Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter
BRPI0519000A2 (pt) variantes de il-7 com imunogenicidade reduzida
EA200801758A1 (ru) Лекарственные формы, устойчивые к самовольному изменению
ATE426412T1 (de) Adjuvante influenza-vakzine
WO2006076003A3 (en) Vaccinia virus strains
BR112019028185A8 (pt) método para melhorar a doença de refluxo gastroesofágico, dispepsia funcional, ou náusea e vômito associados à quimioterapia, método para preparar domperidona deuterada e composto
ECSP077179A (es) Co-cultivos manejados de organismos que tienen efectos profilacticos y promotores de la salud
NO20060976L (no) Vaksine
MX2013012233A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas sustituidas.
NO20080951L (no) Farmasoytisk blanding for behandling av kardiovaskulaere lidelser
WO2012047267A3 (en) Polyvalent immunogen
DE60011560D1 (de) Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert
WO2018066999A3 (en) Chimeric enterovirus virus-like particles
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
MA32305B1 (fr) Vaccin contre le virus vivant attenue inactive de la fievre catarrhale ovine
WO2007070678A3 (en) Rabies vaccine
WO2012071521A3 (en) Adjuvant

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application